Cargando…

Anti-carbamylated protein antibodies in rheumatoid arthritis patients and their association with rheumatoid factor

OBJECTIVES: To evaluate levels of anti-carbamylated protein (anti-CarP) antibodies in rheumatoid arthritis (RA) patients and to determine their association with serological parameters and disease activity. METHODS: A cross-sectional study involving 105 multiethnic RA patients (48 rheumatoid factor [...

Descripción completa

Detalles Bibliográficos
Autores principales:	Othman, Maizatul A., Ghazali, Wan Syamimee W., Hamid, Wan Zuraida W. A., Wong, Kah K., Yahya, Nurul K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Saudi Medical Journal 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5654028/ https://www.ncbi.nlm.nih.gov/pubmed/28889152 http://dx.doi.org/10.15537/smj.2017.9.20841

Ejemplares similares

Anti-cyclic citrullinated peptide antibody is highly associated with rheumatoid factor and radiological defects in rheumatoid arthritis patients
por: Sulaiman, Farah Nadiah, et al.
Publicado: (2019)

Anti-Cyclic Citrullinated Peptide Antibody and Periodontal Status in Rheumatoid Arthritis Patients
por: Mohamad, Wan Majdiah Wan, et al.
Publicado: (2018)

The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis
por: Shi, Jing, et al.
Publicado: (2015)

The Usefulness of Endothelial Cell Adhesion Molecules and Anti-C1q Antibody in Monitoring Systemic Lupus Erythematosus Disease Activity
por: Mahayidin, Hasni, et al.
Publicado: (2014)

Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis
por: Li, Liubing, et al.
Publicado: (2016)

The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patients
por: van Delft, Myrthe A. M., et al.
Publicado: (2017)

Citrullination and Carbamylation in the Pathophysiology of Rheumatoid Arthritis
por: Pruijn, Ger J. M.
Publicado: (2015)

Anti-Carbamylated Protein Antibodies as a Reproducible Independent Type of Rheumatoid Arthritis Autoantibodies
por: Montes, Ariana, et al.
Publicado: (2016)

From Rheumatoid Factor to Anti-Citrullinated Protein Antibodies and Anti-Carbamylated Protein Antibodies for Diagnosis and Prognosis Prediction in Patients with Rheumatoid Arthritis
por: Wu, Chao-Yi, et al.
Publicado: (2021)

Anti-Carbamylated Protein (Anti-CarP) Antibodies in Patients Evaluated for Suspected Rheumatoid Arthritis
por: Ricchiuti, Vincent, et al.
Publicado: (2022)

Anti-carbamylated protein antibody isotype pattern differs between palindromic rheumatism and rheumatoid arthritis
por: Castellanos-Moreira, Raul, et al.
Publicado: (2020)

Rheumatoid factor isotypes in relation to antibodies against citrullinated peptides and carbamylated proteins before the onset of rheumatoid arthritis
por: Brink, Mikael, et al.
Publicado: (2016)

Anti-Carbamylated LL37 Antibodies Promote Pathogenic Bone Resorption in Rheumatoid Arthritis
por: O’Neil, Liam J., et al.
Publicado: (2021)

Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
por: Spinelli, Francesca Romana, et al.
Publicado: (2017)

Anti-carbamylated protein autoantibodies associated with mortality in Spanish rheumatoid arthritis patients
por: Vidal-Bralo, Laura, et al.
Publicado: (2017)

Erratum to: Association between antibodies to carbamylated proteins and subclinical atherosclerosis in rheumatoid arthritis patients
por: Spinelli, Francesca Romana, et al.
Publicado: (2017)

Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage
por: Brink, Mikael, et al.
Publicado: (2015)

Neutrophil-mediated carbamylation promotes articular damage in rheumatoid arthritis
por: O’Neil, Liam J., et al.
Publicado: (2020)

Serum rheumatoid factor IgA, anti-citrullinated peptide antibodies with secretory components, and anti-carbamylated protein antibodies associate with interstitial lung disease in rheumatoid arthritis
por: Oka, Shomi, et al.
Publicado: (2022)

Role of Anti–Carbamylated Protein Antibodies Compared to Anti–Citrullinated Protein Antibodies in Indigenous North Americans With Rheumatoid Arthritis, Their First‐Degree Relatives, and Healthy Controls
por: Koppejan, H., et al.
Publicado: (2016)

Increased Serum Levels of Anti-Carbamylated 78-kDa Glucose-Regulated Protein Antibody in Patients with Rheumatoid Arthritis
por: Yu, Hui-Chun, et al.
Publicado: (2016)

Post-translational modifications in rheumatoid arthritis and atherosclerosis: Focus on citrullination and carbamylation
por: Spinelli, Francesca Romana, et al.
Publicado: (2016)

Carbamylation of vimentin is inducible by smoking and represents an independent autoantigen in rheumatoid arthritis
por: Ospelt, Caroline, et al.
Publicado: (2017)

Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies
por: Reed, Evan, et al.
Publicado: (2016)

Impact of Posttranslational Modification in Pathogenesis of Rheumatoid Arthritis: Focusing on Citrullination, Carbamylation, and Acetylation
por: Kwon, Eui-Jong, et al.
Publicado: (2021)

Anti-carbamylated protein antibodies in systemic sclerosis
por: Liem, Sophie I. E., et al.
Publicado: (2023)

Carbamylated albumin is one of the target antigens of anti-carbamylated protein antibodies
por: Nakabo, Shuichiro, et al.
Publicado: (2017)

Older age and diclofenac are associated with increased risk of upper gastrointestinal bleeding in gout patients
por: Wan Ghazali, Wan Syamimee, et al.
Publicado: (2021)

Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritis
por: Verheul, Marije K., et al.
Publicado: (2017)

Carbamylated vimentin represents a relevant autoantigen in Latin American (Cuban) rheumatoid arthritis patients
por: Martínez, Goitybell, et al.
Publicado: (2016)

Value of Measuring Anti-Carbamylated Protein Antibodies for Classification on Early Arthritis Patients
por: Regueiro, Cristina, et al.
Publicado: (2017)

Increased disease activity in early arthritis patients with anti-carbamylated protein antibodies
por: Regueiro, Cristina, et al.
Publicado: (2021)

Low mortality rate in Italian rheumatoid arthritis patients from a tertiary center: putative implication of a low anti-carbamylated protein antibodies prevalence
por: Iacono, Daniela, et al.
Publicado: (2018)

Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases
por: Pecani, Arbi, et al.
Publicado: (2016)

Erratum to: Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases
por: Pecani, Arbi, et al.
Publicado: (2016)

Rheumatoid Arthritis and Anti-Thyroid Antibodies
por: Yavasoglu, Irfan, et al.
Publicado: (2009)

Anti-BIP antibodies in rheumatoid arthritis
por: Panayi, GS, et al.
Publicado: (2003)

Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies
por: Song, Y.W., et al.
Publicado: (2010)

Anti-citrullinated protein antibodies contribute to platelet activation in rheumatoid arthritis
por: Habets, Kim L.L., et al.
Publicado: (2015)

Specificity of Anti-Citrullinated Protein Antibodies in Rheumatoid Arthritis
por: Trier, Nicole H., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gcu4hhdl938a3480lq0mhigamd